Your browser doesn't support javascript.
loading
Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report.
Young, Su Ling; Stanton, Chloe M; Livesey, Benjamin J; Marsh, Joseph A; Cackett, Peter D.
Affiliation
  • Young SL; Princess Alexandra Eye Pavilion, NHS Lothian, Edinburgh, UK. su.young@nhslothian.scot.nhs.uk.
  • Stanton CM; Department of Ophthalmology, University of Edinburgh, Edinburgh, UK. su.young@nhslothian.scot.nhs.uk.
  • Livesey BJ; Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Marsh JA; Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Cackett PD; Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
BMC Ophthalmol ; 22(1): 140, 2022 Mar 26.
Article in En | MEDLINE | ID: mdl-35346118
ABSTRACT

BACKGROUND:

Usher Syndrome is the commonest cause of inherited blindness and deafness. The condition is clinically and genetically heterogeneous, with no current treatment. We report a case carrying novel biallelic variants in USH2A causing progressive early adolescent onset visual and hearing impairment consistent with Usher Syndrome Type IIA. CASE PRESENTATION Our patient presented at age 13 with progressive visual field loss and hearing loss, associated with early onset of cataract in her 40s requiring lens extraction. Now 52 years old, latest best corrected visual acuity (BCVA) stands at Logmar Right Eye (RE) 0.8 and Left Eye (LE) 0.2, with significantly constricted visual fields bilaterally. She was registered partially sighted age 46. Clinical and molecular genetic assessment of the proband was consistent with a diagnosis of Usher Syndrome Type IIA. Genetic testing identified two novel USH2A variants, resulting in the premature termination codon p.Leu30Ter and a missense mutation p.Cys3251Tyr. Segregation analysis confirmed that these variants were biallelic in the affected case. Comprehensive in silico analysis confirmed that these mutations are the probable cause of Usher Syndrome Type IIA in this individual.

CONCLUSIONS:

The identification of novel mutations in USH2A increases the spectrum of genetic variations that lead to Usher Syndrome, aiding genetic diagnosis, assessment of patient prognosis, and emphasising the importance of genetic testing to identify new mutations in patients with undiagnosed progressive visual loss.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Usher Syndromes Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Female / Humans / Middle aged Language: En Journal: BMC Ophthalmol Journal subject: OFTALMOLOGIA Year: 2022 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Usher Syndromes Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Female / Humans / Middle aged Language: En Journal: BMC Ophthalmol Journal subject: OFTALMOLOGIA Year: 2022 Document type: Article Affiliation country: United kingdom